
Premium veterinary grade Praziquantel (CAS 55268-74-1) active pharmaceutical ingredient. Expertly optimized for high-efficacy anthelmintic tablets, companion animal deworming products, and specialized veterinary parasitic treatment formulations.

Exceptional pharmaceutical purity provides an irreplaceable technical advantage for manufacturing plants formulating complex animal medications. This crystalline active compound works by inducing severe spasms and paralysis in targeted parasites during specific treatment cycles. The unique molecular mechanism successfully helps clinicians manage complex trematode and cestode infestations without causing widespread systemic harm to animal tissue. Furthermore, it helps veterinary material scientists achieve precise stoichiometric controls during large-scale medicinal compounding operations.
Pyrazinoisoquinoline active matrices serve as foundational stabilization agents in modern treatments for canine, feline, and livestock deworming protocols. Consequently, integrating this premium medicinal-grade chemical significantly improves the therapeutic efficacy of your final animal healthcare batch. The formulation also enhances shelf-life stability during extensive international commercial distribution networks. As a result, Zyntex coordinates rigorous lot-by-lot validation for every shipment, ensuring dependable batch-to-batch consistency.
Moreover, Zyntex manages robust international dry-logistics networks designed to preserve the accurate chemical integrity under various transport parameters. This organic pharmaceutical intermediate plays a vital role in fine animal health science. Our specialized compound serves as a reliable benchmark for studying parasite resistance kinetics and specialized metabolic pathways. It opens new operational paths for testing custom veterinary clinical batches. Manufacturers use it as an exact chemical building block for custom therapeutic powders and finished veterinary tablets. At the same time, it remains a critical chemical standard for evaluating active substance behavior. In short, our product functions as a highly dependable veterinary chemical source, safeguarding technical compounding accuracy.
Recently, industrial veterinary interest regarding its implementation in combined broad-spectrum chewable tablet matrices has expanded significantly. The substance offers a clean, low-impurity chemical foundation for discovering modern multi-valent parasitic treatment alternatives. These specialized methods successfully meet strict international veterinary medical agency safety criteria. Because of this, Zyntex offers refined chemical grades designed to satisfy the detailed regulatory processing parameters of manufacturing facilities worldwide. Ultimately, selecting Zyntex guarantees a reliable, fully documented, and robust raw material channel. We blend medical-focused logistics with strict quality assessments. To conclude, our operational dedication ensures that your processes retain the highest possible molecular accuracy and chemical purity.
This high-purity pharmaceutical intermediate is essential across these four primary sectors:
Primary active ingredient for broad-spectrum animal anthelmintic medicine. Thus, it controls tapeworm infections safely and effectively.
Crucial raw material for manufacturing targeted veterinary tablets, pastes, and liquid solutions. Undoubtedly, it supports strict compliance metrics.
Used as a primary starting compound for specialized aquaculture and livestock formulations. Consequently, it enhances processing link longevity.
Acts as a specialized compound standard in veterinary trials and efficacy assays. Specifically, it maintains solution balance and uniformity.
| Parameter | Standard Value |
|---|---|
| Product Name | Praziquantel (Veterinary Grade) |
| Molecular Formula | C19H24N2O2 |
| Assay (Purity) | ≥ 99.0% (Pharmaceutical API Grade) |
| CAS Number | 55268-74-1 |
📝 Safety & Handling: Praziquantel (Veterinary Grade) is a potent active compound and must be handled with appropriate care. Therefore, store in tightly sealed containers within a cool, dry, well-ventilated pharmaceutical laboratory facility away from light and heat. Avoid direct chemical dust inhalation. Wear proper standard pharmaceutical PPE including protective chemical gloves, safety eyewear, and lightweight masks during all compounding phases. Always check the official Safety Data Sheet (SDS) for detailed safety protocols.